In late June I surveyed the end of Aduhelm and looked forward concerning prospects for lecanemab. This week Eisai (OTCPK:ESALY) and Biogen (NASDAQ:BIIB) announced that the Phase 3 CLARITY trial, involving 1,795...
by Martin Armstrong
The Biden Administration reiterated that its $1.9 trillion 2021 American Rescue Plan awarded “resilience” to the US economy. The remarks come after the plan, and the administration’s overall spending, came under harsh criticism...
